The Patent Finder

Tanabe Pharma Corporation

Also on record
Records under this name other than the patents Tanabe Pharma Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 35 patents it holds.

Showing 1 to 3 of 3 · Back to Tanabe Pharma Corporation

PatentTitleStatus Expires Confidence
US 7,511,020Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides
Term ended
Term ended Sep 23, 2024 · From the USPTO record
Term endedTerm ended Sep 23, 2024From the USPTO record
US 7,511,021Substituted indazole-O-glucosides
Term ended
Term ended Sep 15, 2024 · From the USPTO record
Term endedTerm ended Sep 15, 2024From the USPTO record
US 7,482,330Substituted fused heterocyclic C-glycosides
Term ended
Term ended Sep 4, 2024 · From the USPTO record
Term endedTerm ended Sep 4, 2024From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited